XML 25 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 34,530 $ 31,941
Marketable securities available-for-sale 125,669 82,020
Accounts receivable 1,284 9,527
Prepaid expenses and other current assets 4,145 1,130
Total current assets 165,628 124,618
Property and equipment, net 6,833 6,163
Goodwill 2,356 2,312
Restricted cash 640 647
Other assets 438 362
Total assets 175,895 134,102
Current liabilities:    
Accounts payable 1,155 2,040
Accrued liabilities 7,340 8,159
Deferred revenues 2,859 4,210
Note payable to Symphony Dynamo Holdings LLC ("Holdings") 13,905 12,810
Total current liabilities 25,259 27,219
Deferred revenues, noncurrent 5,312 6,386
Other long-term liabilities 616 617
Commitments and contingencies (Note 5)      
Dynavax stockholders' equity:    
Preferred stock: $0.001 par value; 5,000 shares authorized and no shares issued and outstanding at June 30, 2012 and December 31, 2011      
Common stock: $0.001 par value; 250,000 shares authorized; 177,729 and 154,626 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively 178 155
Additional paid-in capital 542,934 466,276
Accumulated other comprehensive loss:    
Unrealized loss on marketable securities available-for-sale (30) (3)
Cumulative translation adjustment (1,217) (1,006)
Total accumulated other comprehensive loss (1,247) (1,009)
Accumulated deficit (397,157) (365,542)
Total stockholders' equity 144,708 99,880
Total liabilities and stockholders' equity $ 175,895 $ 134,102